NYSE$NSP

Insperity Inc · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

Insperity's financial performance decreased in Q2 2023 due to higher healthcare costs, despite revenue growth and strong execution in key drivers.

Insperity reported a decrease in net income and adjusted EBITDA for Q2 2023, primarily due to substantially higher-than-expected benefits costs. However, the average number of WSEEs paid and revenues increased, reflecting strong execution in sales, pricing, client service, and retention.

  • Average number of WSEEs paid increased by 7.2% year-over-year.
  • Revenues increased by 10.7% year-over-year.
  • Net income and diluted EPS decreased by 62% year-over-year.
  • Adjusted EBITDA decreased by 32.2% year-over-year.

Headline financials

Total Revenue

$1.59B

Previous: $1.43B+10.7%
EPS (adj)

$0.64

Previous: $1.16-44.8%
Average Worksite Employees Paid

311.3K

Previous: 290.5K+7.2%
Capital Expenditures

-$14M

Previous: -$9.04M-55.0%
Free Cash Flow

-$1.12M

Previous: $24.6M-104.6%
Net Income

$12.9M

Previous: $33.6M-61.6%
Operating Income

$15.8M

Previous: $48.4M-67.3%
Gross Profit

$225M

Previous: $240M-6.3%
Cash & Equivalents

$580M

Previous: $511M+13.6%
Total Assets

$1.87B

Previous: $1.89B-1.5%
Stock-Based Comp

$15M

No prior period

Revenue & EPS history

Insperity · Revenue · Quarterly

$1.59B

Q2 2023+10.7%vs Q2 2022
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Forward guidance

Insperity updated its guidance for 2023, reflecting the potential impact of elevated healthcare costs on future performance.

Tailwinds

  • Q3 2023 Average WSEEs paid between 315,500 and 317,000
  • Q3 2023 Adjusted EPS between $0.69 and $1.14
  • Q3 2023 Adjusted EBITDA between $57 million and $81 million
  • Full Year 2023 Average WSEEs paid between 314,200 and 315,600
  • Full Year 2023 Adjusted EPS between $4.35 and $5.32

Headwinds

  • Q3 2023 Adjusted EPS year-over-year decrease between (44%) and (7%)
  • Q3 2023 Adjusted EBITDA year-over-year change between (29%) and 1%
  • Full Year 2023 Adjusted EPS year-over-year decrease between (22%) and (5%)
  • Full Year 2023 Adjusted EBITDA year-over-year change between (15%) and (1%)
  • Uncertainty regarding healthcare costs impacting full year guidance

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-1.2%

Avg return

Earnings day

-2.5%

Avg return

5 days after

-2.1%

Avg return

30 days after

50%

34 / 68 earnings

Positive

+17.6%

Q1 2016

Best reaction

-34.2%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.4%-23.2%-7.8%
Q4 2025-10.9%-23.7%-40.0%
Q3 2025-18.0%-24.9%-20.3%
Q1 2025-14.5%-14.9%-17.1%
Q4 2024+16.2%+26.0%+26.0%
Q3 2024-7.3%-5.9%-2.8%
Q2 2024-6.9%-9.1%-8.5%
Q1 2024+0.2%-0.2%-8.0%
Q4 2023-14.8%-18.4%-10.7%
Q3 2023+7.8%+12.5%+17.9%
Q2 2023-18.1%-20.0%-13.9%
Q1 2023+1.6%+2.3%-8.0%
Q4 2022+5.6%+6.6%+6.1%
Q3 2022+12.6%+5.7%+10.6%
Q2 2022-0.8%-0.4%-0.7%
Q1 2022+9.6%+7.2%-0.5%
Q4 2021-17.0%-14.6%-21.5%
Q3 2021-1.4%-2.6%-9.8%
Q2 2021+1.4%+2.9%+11.6%
Q1 2021+0.4%+1.5%+1.4%
Q4 2020-9.3%-12.5%+6.7%
Q3 2020+11.0%+13.5%+13.5%
Q2 2020+3.9%+4.4%+4.1%
Q1 2020+12.6%+15.4%+22.3%
Q4 2019-17.1%-15.0%-41.9%
Q3 2019-34.2%-36.0%-28.1%
Q2 2019-26.4%-29.1%-33.7%
Q1 2019-2.4%-1.0%-7.8%
Q4 2018+12.1%+17.0%+11.4%
Q3 2018+1.2%+3.2%-8.9%
Q2 2018+7.0%+11.9%+26.0%
Q1 2018+7.7%+8.3%+19.9%
Q4 2017+7.5%+10.0%+20.5%
Q3 2017+8.4%+9.9%+20.7%
Q2 2017+11.0%+11.6%+6.4%
Q1 2017-4.7%-9.3%-17.4%
Q4 2016+15.5%+14.9%+22.7%
Q3 2016-13.6%-10.0%-5.5%
Q2 2016-12.8%-12.8%-16.5%
Q1 2016+17.6%
Q4 2015+12.6%
Q3 2015-7.1%
Q2 2015-6.0%
Q1 2015+11.9%
Q4 2014+8.1%
Q3 2014+4.0%
Q2 2014-4.5%
Q1 2014-1.1%
Q4 2013-15.7%
Q3 2013-8.7%
Q2 2013+1.3%
Q1 2013+0.5%
Q4 2012-16.1%
Q3 2012+7.1%
Q2 2012-8.6%
Q1 2012-7.9%
Q4 2011+3.7%
Q3 2011-1.8%
Q2 2011-6.4%
Q1 2010+6.4%
Q1 2011+1.7%
Q4 2008-2.3%
Q4 2010-2.3%
Q3 2009+6.4%
Q3 2010+6.4%
Q2 2010-3.2%
Q4 2009-3.2%
Q2 2009-3.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro